Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2001
10/10/2001EP1140943A2 Substituted pyrroloindoles
10/10/2001EP1140939A1 Substituted 2-aryl-3-(heteroaryl)-imidazo[1,2-alpha]pyrimidines, and related pharmaceutical compositions and methods
10/10/2001EP1140936A1 Tricyclic inhibitors of poly(adp-ribose) polymerases
10/10/2001EP1140924A1 Piperazine derivatives
10/10/2001EP1140923A1 Method for preparing (r)- (+) -3 1- 2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl]- 4-phenylpiperidin -4-yl -1,1- dimethylurea, its salts solvates and/or hydrates
10/10/2001EP1140920A1 Piperidines as ccr5 modulators
10/10/2001EP1140914A1 Non-peptide nk1 receptors antagonists
10/10/2001EP1140911A1 Process for the preparation of an acetate salt of paroxetine or paroxetine analogues
10/10/2001EP1140897A1 Protease inhibitors
10/10/2001EP1140895A2 Thiopyran compounds as inhibitors of mmp
10/10/2001EP1140889A2 Compounds and methods for modulation of estrogen receptors
10/10/2001EP1140873A1 Il-5 inhibiting 6-azauracil derivatives
10/10/2001EP1140860A1 Pyrimidine compounds
10/10/2001EP1140837A1 Compounds useful in the treatment of inflammatory diseases
10/10/2001EP1140835A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
10/10/2001EP1140825A1 Melatonin derivatives and medicine containing same
10/10/2001EP1140818A1 Amidomalonamides and their use as inhibitors of matrix metalloproteinase
10/10/2001EP1140814A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/10/2001EP1140809A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
10/10/2001EP1140792A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by vla-4
10/10/2001EP1140768A1 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
10/10/2001EP1140212A2 The preparation and use of radium-223 to target calcified tissues for pain palliation, bone cancer therapy, and bone surface conditioning
10/10/2001EP1140208A1 Pharmaceutical compositions comprising immortalised endothelial cells
10/10/2001EP1140204A2 Vitronectin receptor antagonist pharmaceuticals
10/10/2001EP1140176A1 Transcutaneous photodynamic treatment of targeted cells
10/10/2001EP1140175A2 Antibodies to truncated vegf-d and uses thereof
10/10/2001EP1140174A1 Agonists or antagonists of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines
10/10/2001EP1140173A2 Vascular endothelial cell growth factor antagonists and uses thereof
10/10/2001EP1140170A1 Novel agents and methods for treatment and diagnosis of ocular disorders
10/10/2001EP1140122A1 Pro-apoptotic agents
10/10/2001EP1140120A2 Human brainiac-5
10/10/2001EP1140118A1 Cyclic adenosine diphosphate ribose analogues for modulating t cell activity
10/10/2001EP1140112A1 Use of etherlysophospholipids as antiinflammatory agents
10/10/2001EP1140098A2 Tricyclic nitrogen heterocycles as pde iv inhibitors
10/10/2001EP1140095A1 (2-imidazoline-2-ylamino) quinoxaline derivatives for the treatment of pain
10/10/2001EP1140091A2 Formulations comprising imiquimod or other immune response modifiers for treating mucosal consitions
10/10/2001EP1140089A1 Liposomic niflumic acid - new transdermal anti-inflammatory medicine
10/10/2001EP1140084A1 Novel formulation
10/10/2001EP1140083A1 Novel compounds
10/10/2001EP1140078A2 Benzimidazole vascular damaging agents
10/10/2001EP1140077A2 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
10/10/2001EP1140076A1 Use of 5ht3-receptor antagonists for the treatment of chronic fatigue syndrome
10/10/2001EP1140072A1 Compounds and methods
10/10/2001EP1140069A1 COMPOUNDS WHICH AFFECT mRNA STABILITY AND USES THEREFOR
10/10/2001EP1140066A1 Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use
10/10/2001EP1140049A2 Compositions and methods to inactivate n-type calcium channels
10/10/2001EP1140048A2 Methods for treating certain diseases using naaladase inhibitors
10/10/2001EP1140032A1 A pharmaceutical mixture comprising a profen
10/10/2001EP1140027A1 Dosage forms comprising porous particles
10/10/2001EP1140021A1 Improved formulation for topical non-invasive application in vivo
10/10/2001EP1140020A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles
10/10/2001EP1140001A2 Composition for treatment of burns
10/10/2001EP1139913A1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents
10/10/2001EP0764163B1 Tachykinin (nk 1) receptor antagonists
10/10/2001CN1317047A GBS toxin receptor
10/10/2001CN1317005A Substituted pyrazole derivatives condensed with six-membered heterocyclic rings
10/10/2001CN1316997A Tripterygium wilfordii lactone prodrugs having high aqueous solubility
10/10/2001CN1316993A 4,4-biarylpiperidime derivatives with opioid receptor activity
10/10/2001CN1316419A Arenesulfonyl amino-iso hydroximic acid derivative
10/10/2001CN1072668C Dihydrobenzofuran and related compounds useful and anti-inflammatory agents
10/10/2001CN1072666C (Azetidin-1-ylalkyl) lactams as tachykinin antagonists
10/10/2001CN1072664C Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compound
10/10/2001CN1072647C Novel inhibitors of bone reabsorption and antagonists of vitronectin receptors
10/09/2001US6300472 Rab proteins
10/09/2001US6300470 Amino acid sequence for the treatment of inflammatory pathology; microbiocides
10/09/2001US6300376 Indane dimer compounds and their pharmaceutical use
10/09/2001US6300372 3-Cyano-3-(3,4-disubstituted) phenylcyclohexyl-1-carboxylates
10/09/2001US6300363 Indole compounds as COX-2 inhibitors
10/09/2001US6300352 For therapy of asthma
10/09/2001US6300347 For therapy of tumor necrosis factor and interleukin-1 mediated diseases such as rheumatoid arthritis and diseases of bone metabolism, e.g. osteoporosis
10/09/2001US6300334 Thieno[2,3-d]pyrimidine-2,4-diones
10/09/2001US6300310 Amino acid sequence with segments of polypeptides
10/09/2001US6299897 Attaching selectin binding carbohydrate to a cross-linkable lipid; attaching an acidic group to a cross linkable lipid; forming lipids into sheet; crosslinking lipids
10/09/2001CA2202057C 5-lipoxygenase inhibitors
10/09/2001CA2161297C Novel diosmetin derivatives; process for preparing the same and pharmaceutical_compositions containing them
10/09/2001CA2016501C Substituted pyrrole compounds and their applications in pharmacy
10/07/2001CA2340936A1 Inhibitors for the formation of soluble human cd23
10/07/2001CA2304906A1 13-hode, a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
10/04/2001WO2001073435A1 Methods for detecting inflammation and inflammatory conditions
10/04/2001WO2001073034A2 Beta-like glycoprotein hormone polypeptide and heterodimer
10/04/2001WO2001073033A2 Anti-angiogenic and anti-tumor properties of matin and other laminin domains
10/04/2001WO2001073018A2 Human tap-like protein (transporter associated in antigen processing/presentation)
10/04/2001WO2001072960A2 Il-8 receptor antagonists
10/04/2001WO2001072845A1 Use of cd25 binding molecules in the treatment of inflammatory diseases of the gastro-intestinal tract
10/04/2001WO2001072836A2 G-protein coupled receptors
10/04/2001WO2001072831A2 Immunoregulator
10/04/2001WO2001072830A2 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction
10/04/2001WO2001072822A2 Genes involved in intestinal inflammatory diseases and use thereof
10/04/2001WO2001072778A2 Method of identifying inhibitors of tie-2
10/04/2001WO2001072777A2 Human transcription factors
10/04/2001WO2001072762A1 Pharmaceutical compositions containing oligosaccharides and preparation thereof
10/04/2001WO2001072758A1 Tricyclic protein kinase inhibitors
10/04/2001WO2001072749A1 Condensed pyrazole derivatives, process for producing the same and use thereof
10/04/2001WO2001072745A1 2-substituted 4-heteroaryl-pyrimidines and their use in the treatmetn of proliferative disorders
10/04/2001WO2001072744A1 N-heterocyclic derivatives as nos inhibitors
10/04/2001WO2001072728A2 Novel piperazine derivatives
10/04/2001WO2001072723A1 Oxa(thia)zolidine derivative and anti-inflammatory drug
10/04/2001WO2001072718A1 Pharmaceutical compositions containing as the active ingredient nitropyrimidine derivatives or salts thereof
10/04/2001WO2001072717A1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
10/04/2001WO2001072711A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
1 ... 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 ... 1272